Screening for ovarian cancer: is it worth the risk?
New screening methods need to be fully evaluated to assess whether they should be introduced in the NHS. This article summarises a systematic review of research on screening for ovarian cancer. There is no evidence that screening reduces the death rate and there is the potential for significant harm from diagnostic surgery in women with false positive results. Screening should be done only within well-conducted research trials.